• Downloads
  • Contact Us
  • Directions
  • Deutsch Deutsch German de
  • English English English en
  • 简体中文 简体中文 Chinese (Simplified) zh-hans
Epitype GmbH
  • Products
  • About us
    • Management
    • Team
    • Research projects
    • Publications
    • Press
    • Jobs
  • Contact
    • Directions
    • Contact Us
  • News / Blog
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

WHO recommends one-dose HPV vaccination for girls

Blog
WHO empfiehlt einmalige HPV-Impfung (xrender/Shutterstock.com)

The World Health Organisation (WHO) recommends the one-dose HPV vaccination of girls and women up to 21 years of age instead of the current two-time vaccination. The WHO wants to increase the vaccination rate in the fight against cervical cancer. In principle, we welcome this plan, but we also have reservations regarding the new recommendation[1].

The fact is, cervical cancer is caused by human papilloma viruses (HPV). While not every HPV infection develops into cervical cancer, there are certain high-risk HPV types. They favour the malignant changes in the cells. There is an effective vaccination against some of these high-risk HPV types. In Germany, the Standing Committee on Vaccination (STIKO) recommends two doses for girls and boys aged 9-14 for sufficient vaccination protection. Those older than 17 should even be vaccinated three times. HPV is sexually transmitted. Condoms do not provide sufficient protection because the viruses are found throughout the intimate and anal areas. For this reason, immunisation is advisable before the first sexual experience.

HPV causes cancer in men and women

It is also a fact that cervical cancer is not the only cancer that can be caused by HPV. In addition to cervical cancer and cancer of the vulva and vagina, an HPV infection can also lead to malignant cell changes in the mouth and throat area, at the anus and also on the penis. Genital warts are also caused by human papilloma viruses. These are harmless, but very unpleasant. Men can not only transmit HPV, but also suffer from HPV-related cancer themselves. In Germany alone, this affects about 1,600 men a year.[2] HPV vaccination also protects against these cancers.

HPV vaccination: useful for girls and boys

Since HPV can cause cancer in both men and women, it is surprising that the WHO focuses its recommendation on cervical cancer – that is, on women. Especially since it also makes sense in the fight against cervical cancer to get boys on board with the vaccination. After all, they can infect their partners with HPV infection as carriers. Since 2018, the Standing Commission on Vaccination in Germany has recommended vaccination against human papilloma viruses for boys aged nine and older.

Dr Cornelia Hösemann (member of the Saxon vaccination commission) takes a very similar view in an interview with the German TV station MDR[3]. In her eyes, the WHO recommendation is a step backwards, because in her opinion, all sexes should be vaccinated from the age of nine. She would like to see a vaccination rate of 80-90 per cent to achieve collective protection. According to a survey by the Robert Koch Institute, the vaccination rate in Germany in 2015 was only around 45 percent[4] among 17-year-olds. This is the age group in which immunisation should ideally already have been completed.

Making HPV vaccination easier – for everyone

The WHO relies on data that show that a single vaccination against HPV ensures full vaccination protection. A single vaccination would mean lower costs, fewer resources, and it would also be easier to administer the vaccination.[5] Thus, access to HPV vaccination would be more low-threshold.

For the time being, the WHO recommendation is only a recommendation. The implementation must be checked by the individual countries themselves. If the vaccination rate can be increased by a simplified HPV vaccination scheme, this is to be welcomed, but then all sexes should be included.

 

Literature sources:

[1] WHO

[2] Robert Koch Institute (RKI)

[3] MDR

[4] Robert Koch Institute (RKI)

[5] WHO

29. April 2022/by Admin Spinger
Share this entry
  • Share on WhatsApp
https://www.epitype.de/wp-content/uploads/2022/04/shutterstock_186488216_blog-scaled.jpg 1881 2560 Admin Spinger https://www.epitype.de/wp-content/uploads/2025/09/epitype_website-logo-300x130.png Admin Spinger2022-04-29 10:28:092023-07-04 10:23:22WHO recommends one-dose HPV vaccination for girls

Archive

Recent Posts

  • Worldwide unique test for cervical cancer as a gamechanger for the healthcare system
  • Jena Biotechnology Company Files for Insolvency
  • Bachelor thesis in biotechnology companies: From research to diagnostics 

Epitype GmbH

The Epitype GmbH, a spin-off of the University Hospital Jena, is a company working on molecular diagnostics with main focus on the development of in-vitro diagnostics based on epigenetic biomarkers.

Epitype GmbH is working according to ISO 13485 standards in research, development, production and management.

Recent Posts

  • Worldwide unique test for cervical cancer as a gamechanger for the healthcare system
  • Jena Biotechnology Company Files for Insolvency
  • Bachelor thesis in biotechnology companies: From research to diagnostics 

Contact

Epitype GmbH
Löbstedter Str. 41
07749 Jena
Germany

Phone: +49 (0)3641 5548500

Email: contact[at]epitype.de
Internet: www.epitype.de

© 2015 - 2025 Epitype GmbH Jena Germany
  • Start
  • Imprint
  • Contact Us
  • Privacy policy
Scroll to top

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn moreI accept

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Privacy policy
Einstellungen akzeptierenVerberge nur die Benachrichtigung
Epitype GmbH
Einwilligung verwalten

Um Ihnen ein optimales Erlebnis zu bieten, verwenden wir Technologien wie Cookies, um Geräteinformationen zu speichern und/oder darauf zuzugreifen. Wenn Sie diesen Technologien zustimmen, können wir Daten wie das Surfverhalten oder eindeutige IDs auf dieser Website verarbeiten. Wenn Sie Ihre Einwilligung nicht erteilen oder zurückziehen, können bestimmte Merkmale und Funktionen beeinträchtigt werden.

Funktional Always active
Die technische Speicherung oder der Zugang ist unbedingt erforderlich für den rechtmäßigen Zweck, die Nutzung eines bestimmten Dienstes zu ermöglichen, der vom Teilnehmer oder Nutzer ausdrücklich gewünscht wird, oder für den alleinigen Zweck, die Übertragung einer Nachricht über ein elektronisches Kommunikationsnetz durchzuführen.
Präferenzen
Die technische Speicherung oder der Zugriff ist für den rechtmäßigen Zweck der Speicherung von Präferenzen erforderlich, die nicht vom Abonnenten oder Benutzer angefordert wurden.
Statistiken
Die technische Speicherung oder der Zugriff, der ausschließlich zu statistischen Zwecken erfolgt. Die technische Speicherung oder der Zugriff, der ausschließlich zu anonymen statistischen Zwecken verwendet wird. Ohne eine Vorladung, die freiwillige Zustimmung deines Internetdienstanbieters oder zusätzliche Aufzeichnungen von Dritten können die zu diesem Zweck gespeicherten oder abgerufenen Informationen allein in der Regel nicht dazu verwendet werden, dich zu identifizieren.
Marketing
Die technische Speicherung oder der Zugriff ist erforderlich, um Nutzerprofile zu erstellen, um Werbung zu versenden oder um den Nutzer auf einer Website oder über mehrere Websites hinweg zu ähnlichen Marketingzwecken zu verfolgen.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
Einstellungen ansehen
  • {title}
  • {title}
  • {title}